In-Person Access Only | 4.50 Earn CME Credits
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $99 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team. Industry representatives—defined as any individual who is employed by, contracted with, owns, or represents a drug, device, diagnostic, or other healthcare-related commercial entity, regardless of clinical credentials or licensure—are not permitted to attend Total Health events as general attendees. Members of industry must contact exhibits@totalhealthoncology.com
The First Annual DEBATING HEMATOLOGY Symposium will bring together nationally recognized leaders in malignant hematology for an engaging, evidence-based forum focused on the most debated topics across hematologic cancers. Through a series of structured debates, expert faculty will examine evolving standards of care, emerging therapeutic approaches, biomarker-driven treatment decisions, and sequencing strategies in diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), multiple myeloma, chronic myeloid leukemia (CML), and myeloproliferative neoplasms (MPNs). Designed to challenge conventional thinking and foster meaningful discussion, the symposium will provide attendees with balanced perspectives, practical clinical insights, and actionable strategies for incorporating the latest evidence into hematology practice.
Conference Agenda
Saturday, March 6, 2027
Program Chairs:
TBD
3:00 - 4:00 PM
Arrival, Networking, and Registration
4:00 - 5:30 PM
Breakout Focus Groups
5:30 - 6:30 PM
Networking Reception
7:00 - 9:00 PM
Faculty Dinner
Sunday, March 7, 2027
7:00 - 8:00 AM
Arrival, Breakfast, and Registration
8:00 - 8:15 AM
Welcome and Opening Remarks
8:15 - 8:45 AM
DLBCL Debate
8:45 - 9:15 AM
MCL Debate
9:15 - 9:45 AM
CLL Debate
9:45 - 10:00 AM
Breakfast & Exhibits
10:00 AM - 10:30 AM
AML Debate
10:30 AM - 11:00 AM
ALL Debate
11:00 AM - 11:30 AM
MDS Debate
11:30 - 12:30 PM
Lunch and Exhibits
12:30 - 1:00 PM
CML Debate
1:00 - 1:30 PM
CML Debate
1:30 - 2:00 PM
MPNs Debate
2:00 - 3:10 PM
Breakout Focus Groups
3:15 PM
ADJOURN
Agenda Subject To Change. All times are CST.
-
-
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Total Health. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Nurses (ANCC) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 ANCC contact hours.
Physicians (ACCME) Credit Designation
Amedco LLC designates this live activity for a maximum of 7.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Pharmacists and Pharmacy Technicians (ACPE) Credit Designation
Amedco LLC designates this activity for a maximum of 7.50 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor.
American Board of Internal Medicine (ABIM) MOC Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.50 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. You must request your certificate within 45 days of the activity to meet the deadline for submission to PARS.
-
Complimentary registration for healthcare professionals
Expert debates on the most controversial and practice-changing topics in malignant hematology
Balanced, evidence-based perspectives from nationally recognized hematology experts
Practical clinical insights to support real-world treatment decision-making across hematologic malignancies
Interactive discussion and networking with faculty, peers, and industry partners
The latest advances in targeted therapies, immunotherapy, cellular therapies, precision medicine, and clinical research in hematology.